This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Sysmex Corporation. Active years: 2019-2020.
Company Filing History:
Years Active: 2019-2020
Title: Innovations of Yukiko Higa
Introduction
Yukiko Higa is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. Her work has led to the filing of multiple patents, showcasing her innovative spirit and dedication to scientific advancement.
Latest Patents
Yukiko Higa holds 2 patents. Her latest patents include a method for detecting AFP, which discloses a monoclonal antibody reactive with a specific glycopeptide. Additionally, she has developed a monoclonal antibody reacting with a glycopeptide that contains a core fucose moiety and specific amino acid residues, highlighting her expertise in antibody development.
Career Highlights
Yukiko Higa is currently employed at Sysmex Corporation, where she continues to push the boundaries of research and innovation. Her work at Sysmex has positioned her as a key player in the biotechnology sector, contributing to advancements that have practical applications in medical diagnostics.
Collaborations
Yukiko collaborates with talented coworkers, including Yuriko Egashira and Yukiko Kataoka. These collaborations enhance her research efforts and foster a creative environment for innovation.
Conclusion
Yukiko Higa's contributions to the field of biotechnology through her patents and work at Sysmex Corporation exemplify her role as a leading inventor. Her innovative approaches to monoclonal antibody development continue to impact the scientific community positively.